October 03, 2024
Trending Now
1
FDA Approves Cobenfy for Schizophrenia
2
Parkinson's Drug Achieves Main Goal in Late-Stage Trial
3
FDA Greenlights New Heart Disease Diagnostic Drug
4
FDA Approves Dupilumab for ‘Smoker's Lung'
5
Aspirin, Heparin May Boost Outcomes in Recurrent Pregnancy Loss
6
Diabetes Screening Practices in Women With PCOS
Conference Coverage
2024 ASCO Quality Care Symposium
2024 IASLC WCLC
2024 European Breast Cancer Conference
Clinical Guidelines
View MoreOctober 01, 2024
Clinical Trial Update October 2024
Commentary & Perspectives
View MoreOctober 03, 2024
Experts Urged Caution on Mouth Taping Trend
October 01, 2024
PAH Study Critique: Selexipag's Real-World Impact
September 27, 2024
WeightWatchers Big Bet on Ozempic a Bust: CEO Steps Down
September 26, 2024
PTSD Widespread Among Nursing Aides After ‘Nightmare’ COVID Conditions
FDA & Government News
View MoreOctober 04, 2024
Regulator Reviews Hair-Loss Drugs Over Suicide Risk
October 04, 2024
Infant RSV Drug Plant Violated FDA Rules, Docs Show
October 03, 2024
Melania Trump Backs Abortion Rights
October 03, 2024
CDC Warns of Overdose Risk from Online Fake Meds
Business Management
View MoreOctober 01, 2024
Win the Battle for Positive Change
October 01, 2024
Viewpoint From the Editor: Another Year Almost Over – How Did We Do?
September 30, 2024
More Females Entering High-Paying Specialties
September 27, 2024